Delivery by 37 weeks is not universally necessary for cholestasis of pregnancy. The timing depends primarily on your bile acid levels. Current guidelines from the Society for Maternal-Fetal Medicine recommend delivery between 36 and 39 weeks when bile acids are below 100 µmol/L, and at 36 weeks when they reach 100 µmol/L or higher. For many women with milder cases, waiting beyond 37 weeks is considered safe.
Why Bile Acid Levels Drive the Timeline
Intrahepatic cholestasis of pregnancy (ICP) causes bile acids to build up in your bloodstream, which is what triggers the intense itching most women notice first. But bile acids also cross the placenta and can affect the baby, and the level of those acids is the single most important factor in deciding when delivery should happen.
The key threshold is 100 µmol/L. Once bile acids reach or exceed that level, the risk of stillbirth rises substantially, particularly as the pregnancy advances into the late third trimester. Research from a large observational study found that among women whose bile acids first crossed the 100 µmol/L mark after 28 weeks, about 9.8% of babies were stillborn, compared to 3.1% when severely elevated levels appeared earlier (before 28 weeks). A later gestational age at which bile acids peak is itself a risk factor for stillbirth, which is why guidelines push for delivery at 36 weeks in severe cases rather than waiting longer.
For women with bile acid levels below 100 µmol/L, the picture is considerably more reassuring. A large U.S. study published in the American Journal of Obstetrics and Gynecology found that stillbirth rates were actually the same or lower among ICP patients compared to women without cholestasis, even when the researchers accounted for the gestational age at delivery. After adjusting for age, socioeconomic factors, and other conditions, women with ICP had a lower absolute rate of stillbirth (0.25%) than those without it (0.38%).
What the Guidelines Actually Say
The Society for Maternal-Fetal Medicine breaks its delivery recommendations into two categories:
- Bile acids below 100 µmol/L: Delivery between 36 weeks 0 days and 39 weeks 0 days. This is a wide window, and where within it you deliver will depend on your symptoms, how your bile acid levels are trending, and your provider’s clinical judgment.
- Bile acids at or above 100 µmol/L: Delivery at 36 weeks 0 days. At this level, the risk of stillbirth climbs sharply in the weeks that follow, so there is little benefit to waiting.
This means the old blanket recommendation of “deliver everyone at 37 weeks” has been replaced by a more individualized approach. If your bile acids are mildly elevated and stable, your provider may be comfortable letting the pregnancy continue closer to 39 weeks. If your levels are rising rapidly or approaching the severe range, earlier delivery makes more sense.
The Role of Itching Severity
It’s tempting to judge how serious your cholestasis is based on how badly you itch, but researchers have cautioned against using the severity of itching alone to decide on early delivery. Itching does not always correlate neatly with bile acid levels. Some women with moderately elevated bile acids experience unbearable itching, while others with very high levels have milder symptoms. Delivery timing should be based on lab values, not symptom intensity.
Does Medication Change the Timeline?
The standard medication prescribed for ICP works by helping your liver process bile acids more efficiently, and it does improve lab values and reduce itching for many women. However, a large randomized controlled trial of 605 patients (the PITCHES trial, published in The Lancet) found no difference in the rates of stillbirth, preterm delivery, or NICU admission between women who took the medication and those who received a placebo.
This doesn’t mean the medication is useless. Symptom relief matters, especially when sleep-disrupting itching is affecting your quality of life. But it does mean that taking the medication does not eliminate the underlying risk to the baby, and it should not change the delivery timeline your provider has set based on your bile acid levels.
When Delivery Before 36 Weeks Is Considered
In rare cases, delivery before 36 weeks may be necessary. If fetal monitoring shows signs that the baby is not tolerating the pregnancy well (called nonreassuring fetal status), delivery can proceed regardless of gestational age. Some providers also perform an amniocentesis before 37 weeks to check fetal lung maturity; if meconium is found in the amniotic fluid at that time, delivery is indicated no matter what the lung maturity results show.
These scenarios are uncommon and involve clinical decisions made in real time. For most women with ICP, the conversation centers on whether delivery happens closer to 36 weeks or closer to 39 weeks, not whether an emergency delivery is needed in the early third trimester.
What This Means for Your Pregnancy
If you’ve been diagnosed with cholestasis and your bile acids are in the mild to moderate range (well below 100 µmol/L), a 37-week delivery is reasonable but not the only option. Your provider may suggest anywhere from 37 to 39 weeks depending on your trend. If your levels are climbing or already above 100 µmol/L, delivery at 36 weeks is strongly recommended because the risk of waiting outweighs the small benefits of additional time in the womb.
The most important thing you can do is have your bile acid levels checked regularly so your provider can track changes over time. A single test result is less informative than the trajectory. Rising levels, especially those approaching 100 µmol/L later in the third trimester, carry more concern than stable, mildly elevated numbers that were caught early.